A prospective study of influenza vaccination and time to pregnancy.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
02 06 2020
Historique:
received: 06 01 2020
revised: 13 04 2020
accepted: 20 04 2020
pubmed: 16 5 2020
medline: 28 4 2021
entrez: 16 5 2020
Statut: ppublish

Résumé

Although pregnancy planners are a priority group for influenza vaccination in the United States, little is known about the extent to which influenza vaccination affects fecundability. We analyzed data from Pregnancy Study Online (PRESTO), an ongoing preconception cohort study of North American pregnancy planners. During June 2013 to August 2019, 8654 female participants and 2137 of their male partners completed a baseline questionnaire and were followed until reported pregnancy, fertility treatment initiation, loss to follow-up, or 12 menstrual cycles of attempt time, whichever came first. At baseline, male and female participants reported whether they received an influenza vaccination in the past year and the date of vaccination. We used proportional probabilities regression models to estimate fecundability ratios (FR) and 95% confidence intervals (CI) comparing those who did and did not report influenza vaccination, adjusting for demographics, anthropometrics, behavioral factors, and medical history. Influenza vaccination in the past year was more common among female participants than male participants (47% vs. 37%). FRs were 1.04 (95% CI: 0.98-1.10) for female vaccination and 1.03 (95% CI: 0.93-1.14) for male vaccination. Among the 2137 couples with complete data on both partners, for 40% neither partner was vaccinated, 23% had female-only vaccination, 9% had male-only vaccination, and in 28% both partners were vaccinated. Compared with couples in which neither participant was vaccinated, FRs were 1.13 for female-only vaccination (95% CI: 0.99-1.29), 0.94 for male-only vaccination (95% CI: 0.78-1.12), and 1.07 when both partners were vaccinated (95% CI: 0.94-1.21). When restricted to recent vaccination before peak influenza season, results were similar. Our data indicate no adverse effect of influenza vaccination on fecundability.

Sections du résumé

BACKGROUND
Although pregnancy planners are a priority group for influenza vaccination in the United States, little is known about the extent to which influenza vaccination affects fecundability.
METHODS
We analyzed data from Pregnancy Study Online (PRESTO), an ongoing preconception cohort study of North American pregnancy planners. During June 2013 to August 2019, 8654 female participants and 2137 of their male partners completed a baseline questionnaire and were followed until reported pregnancy, fertility treatment initiation, loss to follow-up, or 12 menstrual cycles of attempt time, whichever came first. At baseline, male and female participants reported whether they received an influenza vaccination in the past year and the date of vaccination. We used proportional probabilities regression models to estimate fecundability ratios (FR) and 95% confidence intervals (CI) comparing those who did and did not report influenza vaccination, adjusting for demographics, anthropometrics, behavioral factors, and medical history.
RESULTS
Influenza vaccination in the past year was more common among female participants than male participants (47% vs. 37%). FRs were 1.04 (95% CI: 0.98-1.10) for female vaccination and 1.03 (95% CI: 0.93-1.14) for male vaccination. Among the 2137 couples with complete data on both partners, for 40% neither partner was vaccinated, 23% had female-only vaccination, 9% had male-only vaccination, and in 28% both partners were vaccinated. Compared with couples in which neither participant was vaccinated, FRs were 1.13 for female-only vaccination (95% CI: 0.99-1.29), 0.94 for male-only vaccination (95% CI: 0.78-1.12), and 1.07 when both partners were vaccinated (95% CI: 0.94-1.21). When restricted to recent vaccination before peak influenza season, results were similar.
CONCLUSIONS
Our data indicate no adverse effect of influenza vaccination on fecundability.

Identifiants

pubmed: 32409134
pii: S0264-410X(20)30548-X
doi: 10.1016/j.vaccine.2020.04.054
pmc: PMC7360345
mid: NIHMS1586577
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

4246-4251

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD086742
Pays : United States
Organisme : NICHD NIH HHS
ID : R21 HD072326
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Hum Reprod. 2010 Jan;25(1):253-64
pubmed: 19828554
MMWR Morb Mortal Wkly Rep. 2019 Jun 21;68(24):544-551
pubmed: 31220057
Am J Obstet Gynecol. 2017 Dec;217(6):667.e1-667.e8
pubmed: 28917614
Epidemiology. 2016 Jan;27(1):98-104
pubmed: 26484423
J Obstet Gynaecol Can. 2010 May;32(5):443-447
pubmed: 20500952
Paediatr Perinat Epidemiol. 2013 Sep;27(5):491-502
pubmed: 23930785
N Engl J Med. 2010 Jan 7;362(1):27-35
pubmed: 20032319
Int J Epidemiol. 2006 Apr;35(2):337-44
pubmed: 16368725
Fertil Steril. 2013 Jun;99(7):1958-64
pubmed: 23517858
Epidemiology. 1995 Sep;6(5):520-4
pubmed: 8562629
Vaccine. 2013 Oct 1;31(42):4860-6
pubmed: 23954379
Obstet Gynecol. 2010 Apr;115(4):717-726
pubmed: 20308830
Am J Prev Med. 2015 Jun;48(6):647-61
pubmed: 25890684
JAMA Pediatr. 2017 Mar 1;171(3):239-248
pubmed: 27893898
J Assist Reprod Genet. 2017 Apr;34(4):425-430
pubmed: 28188592
Influenza Other Respir Viruses. 2018 Nov;12(6):808-813
pubmed: 30028081
Epidemiology. 2004 Sep;15(5):615-25
pubmed: 15308962
BMJ. 2019 Jul 10;366:l4151
pubmed: 31292120
Stat Med. 2001 May 15-30;20(9-10):1541-9
pubmed: 11343373
Hum Reprod. 2013 Oct;28(10):2856-64
pubmed: 23958939
Lancet Infect Dis. 2012 Jan;12(1):36-44
pubmed: 22032844
Paediatr Perinat Epidemiol. 2015 Jul;29(4):360-71
pubmed: 26111445
PLoS One. 2019 Mar 6;14(3):e0212511
pubmed: 30840644
Public Health. 2016 Sep;138:146-53
pubmed: 27178130
Clin Infect Dis. 2019 May 2;68(10):1623-1630
pubmed: 30204855
Scand J Immunol. 2004 Jan;59(1):1-15
pubmed: 14723616
Obstet Gynecol. 2018 Apr;131(4):e109-e114
pubmed: 29578985
Am J Epidemiol. 1977 Sep;106(3):184-7
pubmed: 900117
Am J Epidemiol. 2007 Feb 15;165(4):444-52
pubmed: 17150983

Auteurs

Olivia R Orta (OR)

Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA. Electronic address: orta@bu.edu.

Elizabeth E Hatch (EE)

Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.

Annette K Regan (AK)

Department of Epidemiology & Biostatistics, School of Public Health, Texas A&M University, College Station, TX, USA; Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA.

Rebecca Perkins (R)

Department of Obstetrics and Gynecology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA.

Amelia K Wesselink (AK)

Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.

Sydney K Willis (SK)

Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.

Ellen M Mikkelsen (EM)

Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus N, Denmark.

Kenneth J Rothman (KJ)

Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA; RTI Health Solutions, Research Triangle Park, Durham, NC, USA.

Lauren A Wise (LA)

Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH